| Fra-1(h) --> uPA(h) (DNA binding).
|
Fra-1(h) --> Scgb1a1(r) (DNA binding).
|
Fra-1(h) --> SFTPD(h) (DNA binding).
|
Fra-1(h) --> FOSL1(h) (DNA binding; transactivation).
|
Fra-1(h) --> IVL(h) (DNA binding).
|
HDAC1(h) + Fra-1(h) <==> Fra-1(h):HDAC1(h) (binding)
|
Fra-1(h) + ubiquitin(h) --> Fra-1(h){ub}n (ubiquitination)
|
Elf-1(h) + Fra-1(h) <==> Elf-1(h):Fra-1(h) (binding) [re.
|
Fra-1(h) --> TNFRSF10A(h) (DNA binding).
|
Fra-1(h) --> GSTP1(h) (DNA binding).
|
JunB(h) + Fra-1(h) <==> JunB(h):Fra-1(h) (binding)
|
Fra-1(h) + BCUR1(h) <==> Fra-1(h):BCUR1(h) (binding)
|
Fra-1(h) + Cocoa(h) <==> Fra-1(h):Cocoa(h) (binding)
|
Fra-1(h) --> MMP1(h) (DNA binding).
|
Fra-1(h) --> MMP2(h) (DNA binding).
|
Fra-1(h) --> IL6(h) (DNA binding).
|
Fra-1(h) --> SPRR1B(h) (DNA binding).
|
Fra-1(h) --> MMP13(h) (DNA binding).
|
Fra-1(h) --> IL11(h) (DNA binding).
|
Fra-1(h) --/ Chk1(h){pS317} (inhibition; decrease of phosphorylation)
|
Fra-1(h) --/ Cdk2(h){pY15} (inhibition; decrease of phosphorylation)
|
Fra-1(h) --> IL2(h) (DNA binding).
|
FOSL1(h) --> Fra-1(h) (expression).
|
IL-17A(h) --> Fra-1(h) (increase of abundance)
|
JNK(h) --> Fra-1(h) (activation; increase of abundance)
|
Fra-1(h) --> Il2(m) (DNA binding).
|
Fra-1(h) --> IL2(h) (DNA binding; transregulation).
|
Fra-1(h) --/ IL8(h) (DNA binding; transrepression).
|
ATFa-isoform3(h) + Fra-1(h) <==> ATFa-isoform3(h):Fra-1(h) (binding)
|
CREBPA-Alpha(h) + Fra-1(h) <==> CREBPA-Alpha(h):Fra-1(h) (binding)
|
c-Jun(h) + Fra-1(h) <==> c-Jun(h):Fra-1(h) (binding)
|
JunB(h) + Fra-1(h) <==> JunB(h):Fra-1(h) (binding)
|
JunD(h) + Fra-1(h) <==> JunD(h):Fra-1(h) (binding)
|
Fra-1(h) + ATF-2-xbb4(h) <==> Fra-1(h):ATF-2-xbb4(h) (binding)
|
Fra-1(h) + FosB(h) <==> Fra-1(h):FosB(h) (binding)
|
MafB(h) + Fra-1(h) <==> MafB(h):Fra-1(h) (binding)
|
c-Jun(m) + Fra-1(h) <==> c-Jun(m):Fra-1(h) (binding)
|
JunB(m) + Fra-1(h) <==> JunB(m):Fra-1(h) (binding)
|
FOSL1(h) --> Fra-1(h) (expression).
|
